The role of medical translations in decentralised clinical trials
Ten years ago, we could not have imagined that COVID would change our lives. Nor could the pharmaceutical companies. In fact, the pandemic forced a rethink of the system in which clinical trials required participants to make numerous visits to hospitals, companies, universities and research...